162 related articles for article (PubMed ID: 33221400)
1. Visible Worms in a Crohn's Patient Treated with Infliximab.
Edelman-Klapper H; Schwartz E; Ben-Horin S
Gastroenterology; 2021 Jun; 160(7):e10-e11. PubMed ID: 33221400
[No Abstract] [Full Text] [Related]
2. Infliximab-induced Liver Injury: A Common Link Between Crohn's Disease and Acute Liver Injury.
Penrice DD; Kamboj AK; Simonetto DA
Inflamm Bowel Dis; 2021 Jan; 27(1):e7-e8. PubMed ID: 32964222
[No Abstract] [Full Text] [Related]
3. Similar But Not Identical: Plaque Psoriasis Exacerbation in a Patient With Crohn's Disease After Switching From CT-P13 to SB2 Infliximab Biosimilar.
Pagnini C; Di Paolo MC; De Angelis G; Torcolacci F; Milano M; Trinca D; Porciello R; Graziani MG
Inflamm Bowel Dis; 2020 Jul; 26(8):e83-e84. PubMed ID: 32458993
[No Abstract] [Full Text] [Related]
4. Eosinophilic Fasciitis in a Patient With Crohn's Disease Treated With Infliximab. A Rare Coexistence or a Drug-related Manifestation?
Mpitouli A; Kougkas N; Avgoustidis N; Ergazakis N; Karmiris K
Inflamm Bowel Dis; 2020 Jul; 26(8):e77-e78. PubMed ID: 32529216
[No Abstract] [Full Text] [Related]
5. Posterior Reversible Encephalopathy Syndrome in a Patient With Crohn's Disease on Infliximab.
Chow S; Patnana S; Gupta NK
J Clin Gastroenterol; 2016 Sep; 50(8):687. PubMed ID: 27306938
[No Abstract] [Full Text] [Related]
6. Cutaneous Pseudolymphoma in a Patient With Crohn's Disease Under Infliximab: First Report.
Carvalhana S; Gonçalves A; Velosa J
J Clin Gastroenterol; 2016; 50(5):436-7. PubMed ID: 26974759
[No Abstract] [Full Text] [Related]
7. [Myiasis caused by Eristalis tenax in Crohn's disease].
Ferrer Bradley I; Navarro Pérez L; Maroto Arce N; López Serrano A; Montón Rodríguez C; Jiménez Mayordomo M; Hinojosa Del Val J
Gastroenterol Hepatol; 2010 Oct; 33(8):616-7. PubMed ID: 20435382
[No Abstract] [Full Text] [Related]
8. A Case of Osteonecrosis of the Jaw in a Patient with Crohn's Disease Treated with Infliximab.
Favia G; Tempesta A; Limongelli L; Crincoli V; Iannone F; Lapadula G; Maiorano E
Am J Case Rep; 2017 Dec; 18():1351-1356. PubMed ID: 29257800
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study.
Ye BD; Pesegova M; Alexeeva O; Osipenko M; Lahat A; Dorofeyev A; Fishman S; Levchenko O; Cheon JH; Scribano ML; Mateescu RB; Lee KM; Eun CS; Lee SJ; Lee SY; Kim H; Schreiber S; Fowler H; Cheung R; Kim YH
Lancet; 2019 Apr; 393(10182):1699-1707. PubMed ID: 30929895
[TBL] [Abstract][Full Text] [Related]
10. Psoriasiform Skin Lesions Are Caused by Both Infliximab and Adalimumab in a Patient with Crohn's Disease.
Cankurtaran E; Ekiz F; Hamamci M; Akinci H; Coskun Y; Yuksel I
Dig Dis Sci; 2016 Apr; 61(4):1206-7. PubMed ID: 26894400
[No Abstract] [Full Text] [Related]
11. Acute Tubulointerstitial Nephritis Associated with Infliximab in a Patient with Crohn's Disease.
Ota M; Iwai H; Imai K; Kamiya M; Yoshihashi-Nakazato Y; Miyasaka N; Kohsaka H
Intern Med; 2016; 55(10):1367-70. PubMed ID: 27181549
[TBL] [Abstract][Full Text] [Related]
12. Infliximab-induced seizures in a patient with Crohn's disease: a case report.
Lv Z; Zhang X; Wu L
BMC Gastroenterol; 2021 Apr; 21(1):193. PubMed ID: 33906621
[TBL] [Abstract][Full Text] [Related]
13. Swift Efficacy with Infliximab 4 Years after Initial Standard Induction Therapy Followed by Severe Delayed Infusion Reaction in Crohn's Disease.
Chiba M; Tsuji T; Nakane K; Obara Y; Komatsu M
Inflamm Bowel Dis; 2020 Jan; 26(1):e4. PubMed ID: 31697829
[No Abstract] [Full Text] [Related]
14. Limited granulomatosis with polyangiitis in an adolescent with Crohn's disease on infliximab therapy: cause or coincidence?
Arora H; Madani S; Debelenko LV; McGrath EJ; Mutyala R; Guglani L
Clin Respir J; 2015 Oct; 9(4):506-11. PubMed ID: 24865526
[TBL] [Abstract][Full Text] [Related]
15. [Pneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn's disease].
Fluxá D; Segovia J; Florenzano M; Salinas J; Flores L; Simian D; Quera R
Rev Chilena Infectol; 2017 Oct; 34(5):518-519. PubMed ID: 29488599
[TBL] [Abstract][Full Text] [Related]
16. Multiple liver abscesses in Crohn's disease in infliximab therapy, successfully treated with antibiotic therapy.
Otheo E; de Blas A; Fortún J; Camarero C
Rev Esp Quimioter; 2019 Dec; 32(6):566-568. PubMed ID: 31660710
[No Abstract] [Full Text] [Related]
17. Visceral Fat Is Associated With Mucosal Healing of Infliximab Treatment in Crohn's Disease.
Shen W; Cao L; Li Y; Cai X; Ge Y; Zhu W
Dis Colon Rectum; 2018 Jun; 61(6):706-712. PubMed ID: 29722729
[TBL] [Abstract][Full Text] [Related]
18. Gummatous cutaneous tuberculosis associated with the use of infliximab for Crohn's disease.
Garcia LC; Vale ECSD; Ferrari ML; Faria LDC
An Bras Dermatol; 2021; 96(2):228-230. PubMed ID: 33593700
[TBL] [Abstract][Full Text] [Related]
19. Asymptomatic Parasitic Infection in a Crohn's Disease Patient on Anti-TNFα Therapy: An Alert for Our Patients?
Cocca S; Guarino M; Cicala M
J Crohns Colitis; 2016 Dec; 10(12):1455-1456. PubMed ID: 27208388
[No Abstract] [Full Text] [Related]
20. SAFETY PROFILE OF ANTI-TNF THERAPY IN CROHN'S DISEASE MANAGEMENT: A BRAZILIAN SINGLE-CENTER DIRECT RETROSPECTIVE COMPARISON BETWEEN INFLIXIMAB AND ADALIMUMAB.
Bau M; Zacharias P; Ribeiro DA; Boaron L; Steckert Filho A; Kotze PG
Arq Gastroenterol; 2017 Dec; 54(4):328-332. PubMed ID: 28954043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
